Harmony Biosciences Holdings, Inc. Interest Payable, Current
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-04
- 2026-06-30: Interest Payable, Current $1.94M.
- 2026-03-31: Interest Payable, Current $1.91M.
- 2025-12-31: Interest Payable, Current $2.15M.
- 2025-09-30: Interest Payable, Current $2.28M.
| Period end | Interest Payable, Current |
|---|---|
| 2026-06-30 | $1.94M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.91M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $2.15M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $2.28M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $2.33M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $2.31M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $2.83M 10-K · filed 2026-02-24 |
| 2024-09-30 | $2.94M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $2.99M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $3.13M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $3.35M 10-K · filed 2025-02-25 |
| 2023-09-30 | $3.14M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $4.20M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $3.83M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $3.29M 10-K · filed 2024-02-22 |
| 2022-09-30 | $3.04M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $2.20M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $2.12M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $2.13M 10-K · filed 2023-02-21 |
| 2021-09-30 | $2.13M 10-Q · filed 2021-11-09 |